Explore more publications!

New Hampshire STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire STEM News.

Press releases published on November 11, 2025

Houzeo Ranks New Hampshire’s Safest Cities to Reside for Homebuyers
Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update
3D Systems Transforming Manufacturing with Introduction of Next-generation Stereolithography Solutions at Formnext 2025
NANOBIOTIX to Participate in Jefferies London Healthcare Conference
NANOBIOTIX participera à la conférence Jefferies London Healthcare
Innventure, Inc. to Announce Third Quarter 2025 Results on November 13, 2025
Lifecore Biomedical to Participate in Upcoming Investor Conferences
Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business
ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.
Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates
Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development
Spectral AI Announces 2025 Third Quarter Financial Results
Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering
BioVaxys Announces Extension of Life Offering Closing Date
Tilray Brands Condemns Misguided Prohibitionist Measures and Champions Responsible Hemp Regulations that Keep Consumers Safe and Businesses Thriving
RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions